This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2014 Nov;38(11):1267-8.

doi: 10.1016/j.leukres.2014.08.003. Epub 2014 Aug 11.

Bendamustine in CLL: How quickly will today's consensus become tomorrow's memory?

PMID: 25260826
DOI: 10.1016/j.leukres.2014.08.003

Editorial

Bendamustine in CLL: How quickly will today's consensus become tomorrow's memory?

B D Cheson. Leuk Res. 2014 Nov.

. 2014 Nov;38(11):1267-8.

doi: 10.1016/j.leukres.2014.08.003. Epub 2014 Aug 11.

Author

PMID: 25260826
DOI: 10.1016/j.leukres.2014.08.003

No abstract available

PubMed Disclaimer

Comment on

Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group.
Cuneo A, Marchetti M, Barosi G, Billio A, Brugiatelli M, Ciolli S, Laurenti L, Mauro FR, Molica S, Montillo M, Zinzani P, Tura S. Cuneo A, et al. Leuk Res. 2014 Nov;38(11):1269-77. doi: 10.1016/j.leukres.2014.06.017. Epub 2014 Jul 7. Leuk Res. 2014. PMID: 25063524

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations